1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

Journal of Neurochemistry

Volumn 123, Issue 6, 2012, Pages 944-953

  Durk, Matthew R ^a   Chan, Gary N Y ^a   Campos, Christopher R ^b   Peart, John C ^b   Chow, Edwin C Y ^a   Lee, Eason ^b   Cannon, Ronald E ^b   Bendayan, Reina ^a   Miller, David S ^b   Pang, K Sandy ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

1 ,25 dihydroxyvitamin D3 and vitamin D receptor; amyloid beta; blood brain barrier; P glycoprotein

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCITRIOL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 6G; VITAMIN D RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CELL TRANSPORT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; MICROVASCULATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN TRANSPORT; RAT; UPREGULATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CALCITRIOL; CELL LINE; ENDOTHELIAL CELLS; HUMANS; LIGANDS; MALE; P-GLYCOPROTEIN; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; UP-REGULATION;

RATTUS; RODENTIA;

EID: 84870595984     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12041     Document Type: Article

References (55)

1. Bauer B., Hartz A. M., Fricker G., and, Miller D. S., (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 66, 413-419.
2. Bauer B., Yang X., Hartz A. M., Olson E. R., Zhao R., Kalvass J. C., Pollack G. M., and, Miller D. S., (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol. Pharmacol. 70, 1212-1219.
3. Bauer B., Hartz A. M., and, Miller D. S., (2007) Tumor necrosis factor α and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 71, 667-675.
4. 3 on breast cells: a mini review. Braz. J. Med. Biol. Res. 35, 1-9.
5. Chan G. N., Hoque M. T., Cummins C. L., and, Bendayan R., (2011) Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. J. Neurochem. 118, 163-175.
6. 3 triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo. Biopharm. Drug Dispos. 30, 457-475.
7. 3 on transporters and enzymes of the rat intestine and kidney in vivo. Biopharm. Drug Dispos. 31, 91-108.
8. 3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo. J. Pharmacol. Exp. Ther. 337, 846-859.
9. Cirrito J. R., Deane R., Fagan A. M., et al,. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model. J. Clin. Invest. 115, 3285-3290.
10. Coty W. A., (1980) A specific, high affinity binding protein for 1α,25-dihydroxy vitamin D in the chick oviduct shell gland. Biochem. Biophys. Res. Commun. 93, 285-292.
11. Deane R., Wu Z., and, Zlokovic B. V., (2004) RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier. Stroke 35, 2628-2631.
12. DeLuca H., (1976) Metabolism of vitamin D: current status. Am. J. Clin. Nutr. 29, 1258-1270.
13. Doran A., Obach R. S., Smith B. J., et al,. (2005) The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab. Dispos. 33, 165-174.
14. Echchgadda I., Song C. S., Roy A. K., and, Chatterjee B., (2004) Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol. Pharmacol. 65, 720-729.
15. 3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Mol. Pharmacol. 76, 1062-1071.
16. Eloranta J. J., Hiller C., Juttner M., and, Kullak-Ublick G. A., (2012) The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor. Mol. Pharmacol. 82, 37-46.
17. 3 and vitamin D analogs, in the Caco-2 cell monolayer. J. Pharmacol. Exp. Ther. 330, 389-402.
18. Gray R. W., Omdahl J. L., Ghazarian J. G., and, DeLuca H. F., (1972) 25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. J. Biol. Chem. 247, 7528-7532.
19. Hartmann T., Bieger S. C., Bruhl B., et al,. (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat. Med. 3, 1016-1020.
20. Hartz A. M., Miller D. S., and, Bauer B., (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease. Mol. Pharmacol. 77, 715-723.
21. Hoque M. T., Robillard K. R., and, Bendayan R., (2012) Regulation of breast cancer resistant protein by peroxisome proliferator-activated receptor α in human brain microvessel endothelial cells. Mol. Pharmacol. 81, 598-609.
22. Ito S., Ueno T., Ohtsuki S., and, Terasaki T., (2010) Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-β peptide(1-40) in mouse: involvement of an LRP-1-independent pathway. J. Neurochem. 113, 1356-1363.
23. 3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 8, 20.
24. 2D, the preferred substrate for CYP24. J. Bone Miner. Res. 17, 179-181.
25. Khan A. A., Chow E. C., van Loenen-Weemaes A. M., Porte R. J., Pang K. S., and, Groothuis G. M., (2009) Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur. J. Pharm. Sci. 37, 115-125.
26. Kim R. B., (2002) Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab. Rev. 34, 47-54.
27. Kim R. B., Fromm M. F., Wandel C., Leake B., Wood A. J., Roden D. M., and, Wilkinson G. R., (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101, 289-294.
28. 3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance. Basic Clin. Pharmacol. Toxicol. 109, 97-102.
29. Lam F. C., Liu R., Lu P., Shapiro A. B., Renoir J. M., Sharom F. J., and, Reiner P. B., (2001) β-Amyloid efflux mediated by p-glycoprotein. J. Neurochem. 76, 1121-1128.
30. Lee G., Dallas S., Hong M., and, Bendayan R., (2001) Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol. Rev. 53, 569-596.
31. Lowry O. H., Rosebrough N. J., Farr A. L., and, Randall R. J., (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
32. 3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells. Eur. J. Pharm. Sci. 46, 149-166.
33. Marquez B., and, Van Bambeke F., (2011) ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr. Drug Targets 12, 600-620.
34. 3 interacts with curcuminoids to stimulate amyloid-β clearance by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 17, 703-717.
35. Miller D. S., (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol. Sci. 31, 246-254.
36. Miller D. L., Papayannopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K., and, Iqbal K., (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301, 41-52.
37. Miller D. S., Nobmann S. N., Gutmann H., Toeroek M., Drewe J., and, Fricker G., (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58, 1357-1367.
38. 3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. J. Alzheimers Dis. 29, 51-62.
39. Muindi J. R., Peng Y., Potter D. M., Hershberger P. A., Tauch J. S., Capozzoli M. J., Egorin M. J., Johnson C. S., and, Trump D. L., (2002) Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin. Pharmacol. Ther. 72, 648-659.
40. Narang V. S., Fraga C., Kumar N., Shen J., Throm S., Stewart C. F., and, Waters C. M., (2008) Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am. J. Physiol. Cell Physiol. 295, C440-C450.
41. Ohtsuki S., Ito S., and, Terasaki T., (2010) Is P-glycoprotein involved in amyloid-β elimination across the blood-brain barrier in Alzheimer's disease? Clin. Pharmacol. Ther. 88, 443-445.
42. Ponchon G., Kennan A. L., and, DeLuca H. F., (1969) " Activation" of vitamin D by the liver. J. Clin. Invest. 48, 2032-2037.
43. Querfurth H. W., and, LaFerla F. M., (2010) Alzheimer's disease. N. Engl. J. Med. 362, 329-344.
44. Saeki M., Kurose K., Tohkin M., and, Hasegawa R., (2008) Identification of the functional vitamin D response elements in the human MDR1 gene. Biochem. Pharmacol. 76, 531-542.
45. Schinkel A. H., Smit J. J., van Tellingen O., et al,. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
46. 3. Mol. Pharmacol. 51, 741-754.
47. Slatopolsky E., and, Brown A. J., (1997) Vitamin D and its analogs in chronic renal failure. Osteoporos. Int. 7 (Suppl 3), S202-S208.
48. 3. Mol. Pharmacol. 60, 1399-1406.
49. Timsit Y. E., and, Negishi M., (2007) CAR and PXR: the xenobiotic-sensing receptors. Steroids 72, 231-246.
50. Tirona R. G., and, Kim R. B., (2005) Nuclear receptors and drug disposition gene regulation. J. Pharm. Biomed. Anal. 94, 1169-1186.
51. Tsuji A., Tamai I., Sakata A., Tenda Y., and, Terasaki T., (1993) Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46, 1096-1099.
52. Wang X., Sykes D. B., and, Miller D. S., (2010) Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol. Pharmacol. 78, 376-383.
53. Weksler B. B., Subileau E. A., Perriere N., et al,. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19, 1872-1874.
54. Zastre J. A., Chan G. N., Ronaldson P. T., Ramaswamy M., Couraud P. O., Romero I. A., Weksler B., Bendayan M., and, Bendayan R., (2009) Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J. Neurosci. Res. 87, 1023-1036.
55. Zlokovic B. V., Yamada S., Holtzman D., Ghiso J., and, Frangione B., (2000) Clearance of amyloid β-peptide from brain: transport or metabolism? Nat. Med. 6, 718.